Components of the Canonical and Non-Canonical Wnt Pathways Are Not Mis-Expressed in Pituitary Tumors

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Colli, Leandro Machado ^a   Saggioro, Fabiano ^a   Serafini, Luciano Neder ^a   Camargo, Renata Costa ^a   Machado, Helio Rubens ^a   Moreira, Ayrton Custodio ^a   Antonini, Sonir R ^a   de Castro, Margaret ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN1 PROTEIN; CYCLIN D1; DISHEVELLED 1; DISHEVELLED 2; DISHEVELLED 3; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; PHOSPHOLIPASE C BETA1; PRICKLE PROTEIN; PROTEIN AKT1; PROTEIN CAMK2A; PROTEIN CTNNB1; PROTEIN DKK3; PROTEIN KINASE C ALPHA; PROTEIN MYB; PROTEIN NFAT5; PROTEIN P53; PROTEIN SPRY1; PROTEIN WISP2; SECRETED FRIZZLED RELATED PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR 7; TUMOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VANGL1 PROTEIN; WNT11 PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN;

AKT1 GENE; ARTICLE; AXIN1 GENE; CAMK2A GENE; CANCER GROWTH; CARCINOGENESIS; CELL POLARITY; CHP GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CTNNB1 GENE; CYCLIN D1 GENE; DAAM1 GENE; DISHEVELLED 1 GENE; DISHEVELLED 2 GENE; DISHEVELLED 3GENE; DKK3 GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GLYCOGEN SYNTHASE KINASE 3BETA GENE; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; NFAT5 GENE; ONCOGENE MYB; ONCOGENE MYC; OUTCOME ASSESSMENT; PHOSPHOLIPASE C BETA1 GENE; PRICKLE GENE; PROTEIN EXPRESSION; PROTEIN KINASE C ALPHA GENE; PTK7 GENE; RECURRENT CANCER; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN GENE; SECRETED FRIZZLED RELATED PROTEIN 1 GENE; SPRY1 GENE; STRESS ACTIVATED PROTEIN KINASE 1 GENE; TRANSCRIPTION FACTOR 7 GENE; TUMOR GENE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UVOMORULIN GENE; VANGL1 GENE; WISP2 GENE; WNT SIGNALING PATHWAY; WNT11 GENE; WNT4 GENE; WNT5A GENE;

CLUSTER ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; WNT SIGNALING PATHWAY;

CHANDIPURA VIRUS;

EID: 84876840190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062424     Document Type: Article

References (45)

1. Melmed S, (2011) Pathogenesis of pituitary tumors. Nature reviews Endocrinology 7: 257-266.
2. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, et al. (2002) Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clinical endocrinology 57: 443-448.
3. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, et al. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer research 57: 5446-5451.
4. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, et al. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proceedings of the National Academy of Sciences of the United States of America 103: 15558-15563.
5. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, et al. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science (New York, NY) 312: 1228-1230.
6. Gueorguiev M, Grossman AB, (2011) Pituitary tumors in 2010: a new therapeutic era for pituitary tumors. Nature reviews Endocrinology 7: 71-73.
7. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annual review of cell and developmental biology 20: 781-810.
8. Chen X, Yang J, Evans PM, Liu C, (2008) Wnt signaling: the good and the bad. Acta biochimica et biophysica Sinica 40: 577-594.
9. Burgess AW, Faux MC, Layton MJ, Ramsay RG, (2011) Wnt signaling and colon tumorigenesis-a view from the periphery. Experimental cell research 317: 2748-2758.
10. Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE, Yunes JA, et al. (2011) Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors. The Journal of clinical endocrinology and metabolism 96: 3106-3114.
11. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, et al. (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. The American journal of pathology 161: 1997-2001.
12. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, et al. (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta neuropathologica 109: 589-597.
13. Hölsken A, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R, (2010) Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta neuropathologica 119: 631-639.
14. Campanini ML, Colli LM, Paixao BMC, Cabral TPF, Amaral FC, et al. (2010) CTNNB1 Gene Mutations, Pituitary Transcription Factors, and MicroRNA Expression Involvement in the Pathogenesis of Adamantinomatous Craniopharyngiomas. Hormones and Cancer.
15. Semba S, Han SY, Ikeda H, Horii a, (2001) Frequent nuclear accumulation of beta-catenin in pituitary adenoma. Cancer 91: 42-48.
16. Sun C, Yamato T, Kondo E, Furukawa T, Ikeda H, et al. (2005) Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1. Journal of neuro-oncology 73: 131-134.
17. Tziortzioti V, Ruebel KH, Kuroki T, Jin L, Scheithauer BW, et al. (2001) Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues. Endocrine pathology 12: 125-136.
18. Angers S, Moon RT, (2009) Proximal events in Wnt signal transduction. Nature reviews Molecular cell biology 10: 468-477.
19. Sheldahl LC, Slusarski DC, Pandur P, Miller JR, Kühl M, et al. (2003) Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. The Journal of cell biology 161: 769-777.
20. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, et al. (2009) Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28: 3197-3208.
21. Medyouf H, Ghysdael J, (2008) The calcineurin/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors. Cell cycle (Georgetown, Tex) 7: 297-303.
22. Katoh M, (2005) WNT/PCP signaling pathway and human cancer (review). Oncology reports 14: 1583-1588.
23. Sugimura R, Li L, (2010) Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth defects research Part C, Embryo today: reviews 90: 243-256.
24. Jenei V, Sherwood V, Howlin J, Linnskog R, Säfholm A, et al. (2009) A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proceedings of the National Academy of Sciences of the United States of America 106: 19473-19478.
25. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, et al. (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer research 66: 10439-10448.
26. Ripka S, König A, Buchholz M, Wagner M, Sipos B, et al. (2007) WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28: 1178-1187.
27. Gueorguiev M, Grossman AB, (2009) Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis. Pituitary 12: 245-255.
28. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M, (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic acids research 40: D109-14.
29. Pabinger S, Thallinger GG, Snajder R, Eichhorn H, Rader R, et al. (2009) QPCR: Application for real-time PCR data management and analysis. BMC bioinformatics 10: 268.
30. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. Available: http://www.r-project.org.
31. Zieglschmid V, Hollmann C, Gutierrez B, Krehan A, Kaul S,et al. (n.d.) Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells. Anticancer research 27: 1769-1776.
32. Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, et al. (2013) DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Science translational medicine 5: 169ra10.
33. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540.
34. Hlubek F, Brabletz T, Budczies J, Pfeiffer S, Jung A, et al. (2007) Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. International journal of cancer Journal international du cancer 121: 1941-1948.
35. Davies SR, Davies ML, Sanders A, Parr C, Torkington J, et al. (2010) Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. International journal of oncology 36: 1129-1136.
36. Banerjee S, Dhar G, Haque I, Kambhampati S, Mehta S, et al. (2008) CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer research 68: 7606-7612.
37. Ferrand N, Stragier E, Redeuilh G, Sabbah M, (2012) Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells. The Biochemical journal 447: 71-79.
38. Miyakoshi T, Takei M, Kajiya H, Egashira N, Takekoshi S, et al. (2008) Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway. Endocrine pathology 19: 261-273.
39. Duong MT, Akli S, Wei C, Wingate HF, Liu W, et al. (2012) LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients. PLoS genetics 8: e1002538.
40. Miyata N, Azuma T, Hozawa S, Higuchi H, Yokoyama A, et al. (2012) Transforming Growth Factor β and Ras/MEK/ERK Signaling Regulate the Expression Level of a Novel Tumor Suppressor Lefty. Pancreas.
41. Yagyu R, Hamamoto R, Furukawa Y, Okabe H, Yamamura T, et al. (2002) Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. International journal of oncology 20: 1173-1178.
42. Kibar Z, Torban E, McDearmid JR, Reynolds A, Berghout J, et al. (2007) Mutations in VANGL1 associated with neural-tube defects. The New England journal of medicine 356: 1432-1437.
43. Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, et al. (2011) Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proceedings of the National Academy of Sciences of the United States of America 108: 11482-11487.
44. Howng S-L, Wu C-H, Cheng T-S, Sy W-D, Lin P-CK, et al. (2002) Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors. Cancer letters 183: 95-101.
45. Castinetti F, Davis SW, Brue T, Camper SA, (2011) Pituitary stem cell update and potential implications for treating hypopituitarism. Endocrine reviews 32: 453-471.